HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jianyong Li Selected Research

Anemia

1/2023Severe hemolytic exacerbations of Chinese PNH patients infected SARS-CoV-2 Omicron.
1/2021Flumatinib versus Imatinib for Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia: A Phase III, Randomized, Open-label, Multi-center FESTnd Study.
12/2015Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jianyong Li Research Topics

Disease

42Neoplasms (Cancer)
12/2023 - 01/2009
27B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
03/2024 - 10/2010
22Leukemia
05/2024 - 12/2008
18Multiple Myeloma
08/2023 - 10/2011
17Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
05/2024 - 09/2000
14BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
05/2024 - 12/2005
13Malaria
08/2018 - 03/2006
12Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
07/2024 - 11/2012
10Lymphoma (Lymphomas)
04/2024 - 04/2014
8Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2024 - 10/2010
8Neutropenia
01/2023 - 02/2015
7Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
11/2017 - 12/2000
6Inflammation (Inflammations)
02/2024 - 08/2011
6Disease Progression
01/2022 - 10/2008
5Thrombosis (Thrombus)
02/2024 - 01/2020
5Carcinogenesis
12/2023 - 11/2004
5Residual Neoplasm
12/2023 - 09/2000
5Splenomegaly
01/2022 - 12/2005
5Diarrhea
01/2022 - 12/2015
5Mycoses (Diseases, Fungus)
08/2021 - 01/2016
5Myelodysplastic Syndromes (Myelodysplastic Syndrome)
07/2021 - 02/2015
4Acute Kidney Injury (Acute Renal Failure)
01/2023 - 09/2020
4Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome)
01/2023 - 07/2011
4Hematologic Neoplasms (Hematological Malignancy)
08/2021 - 02/2015
4Pure Red-Cell Aplasia
07/2021 - 08/2018
4Pain (Aches)
01/2021 - 03/2013
3COVID-19
04/2024 - 01/2023
3Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
04/2024 - 01/2022
3Neurodegenerative Diseases (Neurodegenerative Disease)
02/2024 - 09/2012
3Thrombocytopenia (Thrombopenia)
01/2024 - 10/2019
3Atrial Fibrillation
01/2024 - 01/2022
3T-Cell Lymphoma (Lymphoma, T Cell)
07/2023 - 07/2021
3Waldenstrom Macroglobulinemia (Macroglobulinemia)
03/2023 - 07/2021
3Anemia
01/2023 - 12/2015
3Fever (Fevers)
01/2022 - 12/2013
3Hematologic Diseases (Blood Diseases)
08/2021 - 07/2016
3Blast Crisis (Blast Phase)
01/2021 - 07/2012
3Philadelphia Chromosome
01/2021 - 07/2012
3Hypercholesterolemia
01/2020 - 01/2018
3Fatigue
01/2018 - 07/2015

Drug/Important Bio-Agent (IBA)

12Proteins (Proteins, Gene)FDA Link
01/2022 - 12/2005
10Rituximab (Mabthera)FDA Link
04/2024 - 10/2010
10Agammaglobulinaemia Tyrosine KinaseIBA
10/2023 - 11/2020
8ibrutinibIBA
01/2023 - 12/2015
8EnzymesIBA
12/2020 - 11/2004
8DecitabineFDA Link
11/2018 - 03/2015
7Imatinib Mesylate (Gleevec)FDA Link
05/2024 - 10/2010
7Chimeric Antigen ReceptorsIBA
01/2023 - 11/2018
7zanubrutinibIBA
01/2023 - 11/2020
6aspirin eugenol esterIBA
02/2024 - 12/2013
6DNA (Deoxyribonucleic Acid)IBA
01/2024 - 04/2008
6Cyclophosphamide (Cytoxan)FDA LinkGeneric
10/2023 - 01/2012
6Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
03/2023 - 03/2014
6Circular RNAIBA
09/2022 - 01/2019
6Tyrosine Kinase InhibitorsIBA
06/2019 - 09/2014
5Indicators and Reagents (Reagents)IBA
03/2024 - 01/2020
5Prednisone (Sone)FDA LinkGeneric
10/2023 - 01/2012
5Biomarkers (Surrogate Marker)IBA
01/2022 - 10/2014
5Cytarabine (Cytosar-U)FDA LinkGeneric
11/2018 - 03/2015
5AcetylcholinesteraseIBA
08/2018 - 01/2012
5InsecticidesIBA
01/2017 - 04/2006
4RNA (Ribonucleic Acid)IBA
05/2024 - 01/2018
4Bortezomib (Velcade)FDA Link
03/2024 - 01/2009
4LipidsIBA
12/2023 - 12/2017
4Thalidomide (Thalomid)FDA Link
10/2023 - 01/2009
4Cyclosporine (Ciclosporin)FDA LinkGeneric
10/2023 - 08/2018
4oxidized low density lipoproteinIBA
04/2023 - 01/2017
4Hemoglobins (Hemoglobin)IBA
01/2023 - 07/2016
4AntigensIBA
05/2021 - 12/2000
4alirocumabIBA
10/2020 - 01/2018
4Dasatinib (BMS 354825)FDA Link
06/2019 - 09/2014
4Granulocyte Colony-Stimulating Factor (G-CSF)IBA
11/2018 - 03/2015
4CarbamatesIBA
10/2016 - 01/2012
3Therapeutic UsesIBA
03/2024 - 05/2009
3AnticoagulantsIBA
02/2024 - 06/2023
3venetoclaxIBA
01/2024 - 09/2021
3Fatty Acids (Saturated Fatty Acids)IBA
12/2023 - 01/2020
3Phosphotransferases (Kinase)IBA
12/2023 - 12/2016
3N- (2- amino- 5- fluorobenzyl)- 4- (N- (pyridine- 3- acrylyl)aminomethyl)benzamideIBA
10/2023 - 01/2018
3AlbuminsIBA
07/2023 - 01/2022
3Transcription Factors (Transcription Factor)IBA
03/2023 - 05/2009
3Alanine Transaminase (SGPT)IBA
01/2023 - 01/2021
3Long Noncoding RNAIBA
12/2022 - 01/2018
3Histone Deacetylase InhibitorsIBA
01/2022 - 01/2018
3bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA
01/2022 - 02/2021
3CytokinesIBA
01/2022 - 03/2009
3Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2022 - 04/2014
3Adrenal Cortex Hormones (Corticosteroids)IBA
08/2021 - 08/2018
3Messenger RNA (mRNA)IBA
09/2019 - 01/2018
3AclarubicinIBA
11/2018 - 03/2015
3Pyrethrins (Pyrethroids)FDA Link
01/2018 - 10/2016
3Dynamin IIIBA
11/2017 - 10/2016
3Vincristine (Oncovin)FDA LinkGeneric
09/2017 - 01/2012

Therapy/Procedure

40Therapeutics
04/2024 - 03/2011
20Drug Therapy (Chemotherapy)
12/2023 - 04/2010
9Hematopoietic Stem Cell Transplantation
12/2021 - 10/2010
5Transplantation
12/2021 - 04/2007
4Immunotherapy
01/2022 - 04/2010
3Stem Cell Transplantation
01/2023 - 11/2020
3Induction Chemotherapy
10/2019 - 02/2015